Spectral Financial Statements From 2010 to 2025
| EDT Stock | CAD 0.50 0.01 2.04% |
Check Spectral Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spectral Med's main balance sheet or income statement drivers, such as , as well as many indicators such as . Spectral financial statements analysis is a perfect complement when working with Spectral Med Valuation or Volatility modules.
Spectral |
Spectral Med Company Current Valuation Analysis
Spectral Med's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Spectral Med Current Valuation | 149.07 M |
Most of Spectral Med's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spectral Med is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Spectral Med has a Current Valuation of 149.07 M. This is 98.96% lower than that of the Biotechnology sector and 98.09% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.1% higher than that of the company.
Spectral Med Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spectral Med's current stock value. Our valuation model uses many indicators to compare Spectral Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spectral Med competition to find correlations between indicators driving Spectral Med's intrinsic value. More Info.Spectral Med is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Spectral Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Spectral Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Spectral Med Financial Statements
Spectral Med investors utilize fundamental indicators, such as revenue or net income, to predict how Spectral Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 18 people.
Pair Trading with Spectral Med
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.Moving against Spectral Stock
| 0.42 | RY-PJ | Royal Bank | PairCorr |
| 0.36 | RY-PN | Royal Bank | PairCorr |
| 0.35 | JPM | JPMorgan Chase | PairCorr |
| 0.35 | RY-PO | Royal Bank | PairCorr |
| 0.35 | RY | Royal Bank | PairCorr |
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.